Tactile Systems (TCMD) Piper Sandler 37th Annual Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Piper Sandler 37th Annual Healthcare Conference summary
2 Dec, 2025Business performance and strategy
Achieved strong Q3 results with beats and raises in both lymphedema and airway clearance segments, supported by healthy business fundamentals and margin expansion.
Focused on improving access to care, product innovation, and maximizing lifetime value, with ongoing investments translating into business performance.
Transformation efforts are aimed at scaling and streamlining operations for future growth, with continued investment in infrastructure and technology.
Salesforce and CRM transformation
Implemented Salesforce CRM in February, enhancing sales team productivity with integrated analytics and market data.
Completed a major salesforce reset, consolidating territories and hiring over 300 sales reps ahead of schedule to drive revenue.
Current headcount is at target levels, with future additions only as needed for territory splits.
Reimbursement and regulatory landscape
Transitioned from LCD to NCD, initially a challenge but now becoming a tailwind as policy clarity improves.
Direct access to advanced pumps like Flexitouch is now possible, removing previous barriers and expected to benefit Q4 and beyond.
Latest events from Tactile Systems
- Proxy seeks approval for director elections, auditor, executive pay, and governance amendment.TCMD
Proxy Filing10 Mar 2026 - Double-digit revenue and margin growth in 2025, with 2026 guidance for continued expansion.TCMD
Q4 202517 Feb 2026 - Q2 revenue up 7%, net income $4.3M, guidance trimmed, margins and innovation strong.TCMD
Q2 20242 Feb 2026 - Strong growth, new products, and tech investments position for accelerated expansion in 2025.TCMD
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 revenue up 5%, gross margin expands, net income down, $30M buyback program authorized.TCMD
Q3 202417 Jan 2026 - New product launches and policy shifts position the business for growth and operational efficiency in 2025.TCMD
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Strong growth and innovation position the business to lead in a $10B underpenetrated market.TCMD
Oppenheimer 35th Annual Health Care MedTech and Services Conference26 Dec 2025 - Q4 revenue up 10.2%, improved margins, and 2025 guidance targets 8–10% growth.TCMD
Q4 20242 Dec 2025 - Annual meeting covers director elections, compensation, new equity plan, and ESG oversight.TCMD
Proxy Filing1 Dec 2025